Invention Grant
- Patent Title: Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo
-
Application No.: US16467013Application Date: 2017-12-12
-
Publication No.: US11753460B2Publication Date: 2023-09-12
- Inventor: Andrew M. Scharenberg
- Applicant: Seattle Children's Hospital
- Applicant Address: US WA Seattle
- Assignee: Seattle Children's Hospital
- Current Assignee: Seattle Children's Hospital
- Current Assignee Address: US WA Seattle
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/US2017/065746 2017.12.12
- International Announcement: WO2018/111834A 2018.06.21
- Date entered country: 2019-06-05
- Main IPC: C12N15/62
- IPC: C12N15/62 ; C07K14/715
Abstract:
The present application relates to compositions comprising fusion proteins and cells expressing the proteins. The application further relates to methods of using the fusion proteins, cells, and compositions for modulating cell signaling and for selective expansion of cells.
Information query
IPC分类:
